Author Correction: Genetic drivers and cellular selection of female mosaic X chromosome loss

Affiliations

• ¹ Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland. liuaoxin@broadinstitute.org.
• ² Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. liuaoxin@broadinstitute.org.
• ³ Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. liuaoxin@broadinstitute.org.
• ⁴ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. liuaoxin@broadinstitute.org.
• ⁵ Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. liuaoxin@broadinstitute.org.
• ⁶ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. giulio@broadinstitute.org.
• ⁷ Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. giulio@broadinstitute.org.
• ⁸ Department of Genetics, Harvard Medical School, Boston, MA, USA. giulio@broadinstitute.org.
• ⁹ MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
• ¹⁰ Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
• ¹¹ Department of Public Health, University of Helsinki, Helsinki, Finland.
• ¹² Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland.
• ¹³ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ¹⁴ Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA.
• ¹⁵ Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
• ¹⁶ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
• ¹⁷ Department of Medicine, Queen's University, Kingston, Ontario, Canada.
• ¹⁸ Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
• ¹⁹ Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
• ²⁰ Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
• ²¹ Center for Data and Computational Sciences (C-DACS), VA Cooperative Studies Program, VA Boston Healthcare System, Boston, MA, USA.
• ²² Booz Allen Hamilton, McLean, VA, USA.
• ²³ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
• ²⁴ Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
• ²⁵ Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
• ²⁶ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ²⁷ Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
• ²⁸ Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
• ²⁹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ³⁰ Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
• ³¹ Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
• ³² Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
• ³³ Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
• ³⁴ Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
• ³⁵ Department of Genetics, Harvard Medical School, Boston, MA, USA.
• ³⁶ Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan.
• ³⁷ Department of Applied Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
• ³⁸ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. poruloh@broadinstitute.org.
• ³⁹ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. poruloh@broadinstitute.org.
• ⁴⁰ Center for Data Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. poruloh@broadinstitute.org.
• ⁴¹ Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland. andrea.ganna@helsinki.fi.
• ⁴² Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. andrea.ganna@helsinki.fi.
• ⁴³ Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. andrea.ganna@helsinki.fi.
• ⁴⁴ Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. andrea.ganna@helsinki.fi.
• ⁴⁵ MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK. john.perry@mrc-epid.cam.ac.uk.
• ⁴⁶ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. mitchell.machiela@nih.gov.